The Washington Post reports:
In an all-day FDA advisory meeting, experts resoundingly voted down Pfizer’s application for boosters for everyone 16 and older and is now debating whether to authorize an additional dose for older adults. The panelists may choose to green-light boosters for adults in older age brackets and with serious medical conditions that heighten their vulnerability to severe breakthrough disease.
NEWS: FDA’s outside advisors vote 16-3 against Pfizer’s request for boosters for all, a significant hurdle to the White House’s booster rollout.
They’re poised to consider a narrower recommendation on boosters for elderly people.
— Emily Kopp (@emilyakopp) September 17, 2021
BREAKING: A panel of advisers to the FDA recommended against approval of a Pfizer booster shot for people 16 years and older. There may be another vote on boosters for a limited age group.https://t.co/wIBccypRER
— NPR (@NPR) September 17, 2021
BREAKING: Federal advisers have declined to recommend boosters for Americans as young as 16 who took the Pfizer vaccine more than six months ago, although they said they haven’t ruled out third shots for older populations. https://t.co/GOU6a5ZJFF
— ABC News (@ABC) September 17, 2021